Legal & General Group Plc purchased a new position in Concentrix Corporation (NASDAQ:CNXC – Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 148,961 shares of the company’s stock, valued at approximately $3,337,000.
A number of other hedge funds also recently bought and sold shares of CNXC. BlackRock Inc. acquired a new position in shares of Concentrix in the 2nd quarter valued at $149,639,000. AQR Capital Management LLC raised its stake in shares of Concentrix by 1.8% in the third quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock valued at $202,175,000 after acquiring an additional 75,352 shares in the last quarter. Pzena Investment Management LLC acquired a new stake in Concentrix in the second quarter valued at $76,488,000. Dimensional Fund Advisors LP boosted its holdings in shares of Concentrix by 18.5% in the 1st quarter. Dimensional Fund Advisors LP now owns 2,951,378 shares of the company’s stock valued at $80,746,000 after buying an additional 460,108 shares in the last quarter. Finally, Groupe Bruxelles Lambert purchased a new position in Concentrix during the 2nd quarter worth approximately $68,000,000. Institutional investors and hedge funds own 90.34% of the company’s stock.
Concentrix Trading Down 2.1%
NASDAQ:CNXC opened at $32.16 on Friday. Concentrix Corporation has a 12-month low of $19.12 and a 12-month high of $57.88. The firm has a market capitalization of $1.96 billion, a P/E ratio of -1.51, a P/E/G ratio of 0.60 and a beta of 0.47. The company has a debt-to-equity ratio of 1.46, a current ratio of 1.18 and a quick ratio of 1.18. The business has a 50 day simple moving average of $25.41 and a 200 day simple moving average of $27.05.
Concentrix Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, August 4th. Shareholders of record on Friday, July 24th were given a dividend of $0.36 per share. This represents a $1.44 dividend on an annualized basis and a dividend yield of 4.5%. The ex-dividend date was Friday, July 24th. Concentrix’s payout ratio is -6.75%.
Analyst Ratings Changes
Several brokerages recently weighed in on CNXC. Robert W. Baird decreased their price target on Concentrix from $40.00 to $30.00 and set an “outperform” rating for the company in a report on Tuesday, June 30th. Canaccord Genuity Group lowered their price target on shares of Concentrix from $55.00 to $45.00 and set a “buy” rating on the stock in a research report on Tuesday, June 30th. Zacks Research upgraded Concentrix from a “strong sell” rating to a “hold” rating in a report on Monday, August 31st. Barrington Research dropped their price target on Concentrix from $38.00 to $30.00 and set an “outperform” rating for the company in a research note on Tuesday, June 30th. Finally, Bank of America reduced their target price on shares of Concentrix from $32.00 to $26.00 and set a “neutral” rating on the stock in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $32.75.
Get Our Latest Research Report on Concentrix
Concentrix Company Profile
Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.
Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.
Further Reading
- Five stocks we like better than Concentrix
- Revolution Medicines Got Its Breakthrough—What Moves It Next?
- Retail Earnings Just Exposed a Bigger Divide in the U.S. Consumer Economy
- FB Financial’s Southern Expansion and Buybacks Drive Analyst Optimism
- AST SpaceMobile Stock Soared 12%—This Was the Catalyst
Want to see what other hedge funds are holding CNXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Concentrix Corporation (NASDAQ:CNXC – Free Report).
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.
